USANA Health Sciences, Inc. (NYSE:USNA) Director Myron W. Wentz sold 11,835 shares of the firm’s stock in a transaction that occurred on Wednesday, November 15th. The stock was sold at an average price of $66.07, for a total transaction of $781,938.45. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.
Shares of USANA Health Sciences, Inc. (USNA) traded up $0.40 during midday trading on Monday, reaching $70.85. The company’s stock had a trading volume of 85,776 shares, compared to its average volume of 128,106. The stock has a market capitalization of $1,700.00, a price-to-earnings ratio of 18.64 and a beta of 1.08. USANA Health Sciences, Inc. has a 52 week low of $52.55 and a 52 week high of $72.80.
USANA Health Sciences (NYSE:USNA) last announced its earnings results on Tuesday, October 24th. The company reported $1.02 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.91 by $0.11. The company had revenue of $261.77 million for the quarter, compared to analyst estimates of $259.52 million. USANA Health Sciences had a return on equity of 26.38% and a net margin of 8.79%. The firm’s quarterly revenue was up 3.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.40 earnings per share. equities research analysts predict that USANA Health Sciences, Inc. will post 3.7 EPS for the current fiscal year.
Several large investors have recently bought and sold shares of the business. BNP Paribas Arbitrage SA grew its stake in shares of USANA Health Sciences by 13.1% during the second quarter. BNP Paribas Arbitrage SA now owns 2,111 shares of the company’s stock worth $135,000 after purchasing an additional 245 shares in the last quarter. Victory Capital Management Inc. grew its stake in shares of USANA Health Sciences by 17.6% during the second quarter. Victory Capital Management Inc. now owns 2,490 shares of the company’s stock worth $160,000 after purchasing an additional 373 shares in the last quarter. Creative Planning grew its stake in shares of USANA Health Sciences by 528.0% during the second quarter. Creative Planning now owns 2,512 shares of the company’s stock worth $161,000 after purchasing an additional 2,112 shares in the last quarter. SG Americas Securities LLC acquired a new position in shares of USANA Health Sciences during the second quarter worth $162,000. Finally, Cubist Systematic Strategies LLC acquired a new position in shares of USANA Health Sciences during the third quarter worth $189,000. Institutional investors and hedge funds own 43.82% of the company’s stock.
USNA has been the topic of several analyst reports. BidaskClub raised shares of USANA Health Sciences from a “strong sell” rating to a “sell” rating in a research report on Tuesday, August 22nd. Pivotal Research lifted their price target on shares of USANA Health Sciences from $70.00 to $80.00 and gave the company a “buy” rating in a research report on Wednesday, October 25th.
COPYRIGHT VIOLATION WARNING: This story was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The correct version of this story can be viewed at https://www.dispatchtribunal.com/2017/12/04/insider-selling-usana-health-sciences-inc-usna-director-sells-781938-45-in-stock.html.
USANA Health Sciences Company Profile
USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.
Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.